Breaking News Instant updates and real-time market news.

IART

Integra LifeSciences

$52.99

1.19 (2.30%)

06:28
04/24/19
04/24
06:28
04/24/19
06:28

Integra LifeSciences sees Q2 adjusted EPS growth roughly 10% y/y, consensus 65c

Sees Q2 revenue $370M-$375M, consensus $376.53M. Sees organic growth in Q2 3.5%-4%. Guidance provided in Q1 earnings presentation slides.

  • 24

    Apr

  • 16

    May

IART Integra LifeSciences
$52.99

1.19 (2.30%)

12/17/18
FBCO
12/17/18
INITIATION
Target $57
FBCO
Outperform
Integra LifeSciences initiated with an Outperform at Credit Suisse
Credit Suisse analyst Matt Miksic initiated Integra LifeSciences with an Outperform rating and a price target of $57 as part of his broader research note on Medical Supplies and Devices partially titled "No Disruption, No Alpha". The analyst notes that investor confidence in the stock has been "rattled" by the company's recent execution missteps and a top-line miss in Q3, however, he sees the issues as "transitory" and its current stock price as attractive.
01/03/19
RHCO
01/03/19
INITIATION
Target $56
RHCO
Buy
Integra LifeSciences initiated with a Buy at SunTrust
SunTrust analyst Bruce Nudell initiated Integra LifeSciences with a Buy rating and a price target of $56, saying the "temporary" headwinds experienced by the company in Q3 and the subsequent pullback in its stock price present a "buying opportunity". The analyst cites the company's progress in integrating its "Codman acquisition, expanding its geographic footprint, augmenting and optimizing its distribution channels and introducing new products that should drive 5.5% organic growth over the 2018-22 timeframe."
02/21/19
02/21/19
NO CHANGE

Piper reiterates Overweight rating on Integra after Q4 earnings
Piper Jaffray analyst Matt O'Brien reiterated an Overweight rating and $62 price target on Integra LifeSciences after the company reported better-than-expected Q4 earnings, including Q4 sales of $383.3M which represented growth of ~4% and was on the higher end of the company's preannounced range of $378-383M. Additionally, Integra guided for FY19 adjusted earnings of $2.64-$2.72, ahead of Piper's previous estimate of $2.61.
03/11/19
PIPR
03/11/19
NO CHANGE
Target $62
PIPR
Overweight
Integra warning letter 'not the end of the world,' says Piper Jaffray
Piper Jaffray analyst Matt O'Brien says he spoke to Integra LifeSciences after the company disclosed a warning letter relating to its wound care manufacturing facility in Boston. The company emphasized that there were no safety issues associated with the products, O'Brien tells investors in a research note. The analyst does not expect the letter to impact revenue much, if at all. Management believes that it will be able to have the issue resolved within about six months, he adds. These FDA warnings letters happen, and is "not the end of the world" for Integra's wound care business, says O'Brien. He keeps an Overweight rating on Integra LifeSciences with a $62 price target.

TODAY'S FREE FLY STORIES

ZGNX

Zogenix

$39.43

-0.07 (-0.18%)

08:05
06/27/19
06/27
08:05
06/27/19
08:05
Hot Stocks
Zogenix announces FDA agreement to proceed with resubmission of FINTEPLA NDA »

Zogenix announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:05
06/27/19
06/27
08:05
06/27/19
08:05
General news
U.S. initial jobless claims preview: initial claims are expected to rise 5k to 221k »

U.S. initial jobless…

08:05
06/27/19
06/27
08:05
06/27/19
08:05
General news
U.S. Q1 GDP preview: w »

U.S. Q1 GDP preview:…

HTH

Hilltop Holdings

$20.05

0.26 (1.31%)

08:03
06/27/19
06/27
08:03
06/27/19
08:03
Hot Stocks
Hilltop Holdings signs sponsored research agreement with GWU »

Hoth Therapeutics has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 26

    Aug

HQY

HealthEquity

$62.16

-2.5 (-3.87%)

08:03
06/27/19
06/27
08:03
06/27/19
08:03
Conference/Events
HealthEquity to hold a conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

ALRN

Aileron Therapeutics

$0.75

-0.0365 (-4.63%)

08:02
06/27/19
06/27
08:02
06/27/19
08:02
Hot Stocks
Aileron Therapeutics announces FDA acceptance of IND for ALRN-6924 »

Aileron Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$375.05

5.68 (1.54%)

08:02
06/27/19
06/27
08:02
06/27/19
08:02
Recommendations
Boeing analyst commentary  »

BofA continues to see 6-9…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

  • 24

    Jul

CABO

Cable One

$1,111.46

-18.95 (-1.68%)

08:02
06/27/19
06/27
08:02
06/27/19
08:02
Recommendations
Cable One analyst commentary  »

Cable One price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VFC

VF Corp.

$85.74

0.32 (0.37%)

08:01
06/27/19
06/27
08:01
06/27/19
08:01
Recommendations
VF Corp. analyst commentary  »

VF Corp. price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

TSLA

Tesla

$219.22

-0.47 (-0.21%)

08:00
06/27/19
06/27
08:00
06/27/19
08:00
Options
Tesla put buyer realizes 36% same-day gains »

Notable profits for the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COUP

Coupa Software

$119.01

-1.3 (-1.08%)

07:57
06/27/19
06/27
07:57
06/27/19
07:57
Recommendations
Coupa Software analyst commentary  »

Coupa Software price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jul

BB

BlackBerry

$7.55

-0.74 (-8.93%)

07:56
06/27/19
06/27
07:56
06/27/19
07:56
Recommendations
BlackBerry analyst commentary  »

BlackBerry execution…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SM

SM Energy

$12.56

0.63 (5.28%)

07:55
06/27/19
06/27
07:55
06/27/19
07:55
Initiation
SM Energy initiated  »

SM Energy initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

07:55
06/27/19
06/27
07:55
06/27/19
07:55
General news
Oil Action: WTI crude »

Oil Action: WTI crude…

ITRI

Itron

$60.88

0.48 (0.79%)

07:55
06/27/19
06/27
07:55
06/27/19
07:55
Conference/Events
Itron to host investor day »

Investor day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

XEC

Cimarex Energy

$57.17

1.64 (2.95%)

07:53
06/27/19
06/27
07:53
06/27/19
07:53
Initiation
Cimarex Energy initiated  »

Cimarex Energy initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

COUP

Coupa Software

$119.01

-1.3 (-1.08%)

07:52
06/27/19
06/27
07:52
06/27/19
07:52
Recommendations
Coupa Software analyst commentary  »

Coupa Software price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jul

LECO

Lincoln Electric

$79.77

0.1 (0.13%)

07:52
06/27/19
06/27
07:52
06/27/19
07:52
Downgrade
Lincoln Electric rating change  »

Lincoln Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EV

Eaton Vance

$42.13

0.455 (1.09%)

07:50
06/27/19
06/27
07:50
06/27/19
07:50
Conference/Events
Eaton Vance to hold a conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LBC

Luther Burbank

$10.33

-0.13 (-1.24%)

07:50
06/27/19
06/27
07:50
06/27/19
07:50
Upgrade
Luther Burbank rating change at Sandler ONeill »

Luther Burbank upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QIWI

Qiwi

$20.29

0.54 (2.73%)

07:49
06/27/19
06/27
07:49
06/27/19
07:49
Hot Stocks
Qiwi appoints Vladislav Poshmorga as CFO »

QIWI announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KBH

KB Home

$23.58

-0.24 (-1.01%)

07:48
06/27/19
06/27
07:48
06/27/19
07:48
Upgrade
KB Home rating change  »

KB Home upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FIZZ

National Beverage

$42.28

-0.92 (-2.13%)

07:47
06/27/19
06/27
07:47
06/27/19
07:47
Recommendations
National Beverage analyst commentary  »

Guggenheim says National…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HIVE

Aerohive

$4.44

1.26 (39.62%)

07:46
06/27/19
06/27
07:46
06/27/19
07:46
Downgrade
Aerohive rating change at Craig-Hallum »

Aerohive downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMGN

ImmunoGen

$1.95

0.14 (7.73%)

07:45
06/27/19
06/27
07:45
06/27/19
07:45
Conference/Events
ImmunoGen to hold a conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.